Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2001
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001CA2404475A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2404386A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2404384A1 Substituted 1,3-thiazole compounds, their production and use
10/11/2001CA2404376A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001CA2404373A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001CA2404358A1 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001CA2404023A1 Cyclic lactams as inhibitors of a.beta. protein production
10/11/2001CA2403991A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2403550A1 Cyclic lactams as inhibitors of a-.beta. protein production
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders
10/11/2001CA2368966A1 New derivatives and analogues of galanthamine
10/10/2001EP1142903A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1?
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001EP1142881A1 Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
10/10/2001EP1142587A1 Remedies for pain
10/10/2001EP1141728A1 Kidney disease detection and treatment
10/10/2001EP1141407A2 Method of identifying a psychotropic agent using differential gene expression
10/10/2001EP1141364A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
10/10/2001EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors
10/10/2001EP1141340A1 A method for introducing substances into cells, and use of said method
10/10/2001EP1141332A1 Human cyclic nucleotide pdes
10/10/2001EP1141306A2 Streptococcus antigens
10/10/2001EP1141296A2 Interferon-epsilon
10/10/2001EP1141294A1 Method of enhancing the biological activity of ligands
10/10/2001EP1141288A2 Lymphocytic membrane proteins
10/10/2001EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141251A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders
10/10/2001EP1141241A2 Astrocytes, their preparation and uses thereof
10/10/2001EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/10/2001EP1141016A1 Three dimensional structure of a sterile alpha motif domain
10/10/2001EP1141015A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1140981A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
10/10/2001EP1140973A1 Protein-protein interactions in neurodegenerative disorders
10/10/2001EP1140970A1 47 human secreted proteins
10/10/2001EP1140959A1 Inositol-containing hexasaccharides, their synthesis and their uses
10/10/2001EP1140946A2 Quinoline derivatives
10/10/2001EP1140945A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
10/10/2001EP1140940A1 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)qinoxalin-5(6h)one derivates being 5ht2c agonists
10/10/2001EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods
10/10/2001EP1140938A2 High affinity inhibitors for target validation and uses thereof
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140934A1 BENZISOXAZOLES AND PHENONES AS $g(a) 2?-ANTAGONISTS
10/10/2001EP1140931A1 5ht1 antagonists for antidepressant therapy
10/10/2001EP1140929A1 1h-imidazo 4,5-d]pyridazin-7-ones, 3h-imidazo 4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (crf) receptor ligands
10/10/2001EP1140925A1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
10/10/2001EP1140919A1 1,4-disubstituted cyclohexane derivatives for the treatment of depression
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140912A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140911A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140910A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140891A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140882A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140879A1 1-phenyl-4-(1- 2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140875A1 Sulphonyloxazolamines as therapeutic active ingredients
10/10/2001EP1140863A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
10/10/2001EP1140861A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140855A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140838A1 1, 4-piperazine derivatives having 5ht1a receptor activity
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140830A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140815A1 Novel thio-aminotetralin compounds useful in pain management
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140790A1 Novel oxo-aminotetralin compounds useful in pain management
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140207A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same
10/10/2001EP1140201A2 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/10/2001EP1140128A1 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans
10/10/2001EP1140126A1 A nascent gold based herbal composition
10/10/2001EP1140124A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine
10/10/2001EP1140120A2 Human brainiac-5
1 ... 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 ... 1833